Lawrence Otto Klein
CRSPLawrence Otto Klein serves as director, officer: Chief Executive Officer at CRISPR Therapeutics AG (CRSP). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
Lawrence Otto Klein's Insider Trading at CRISPR Therapeutics AG (CRSP)
Buys
0 · $0.00
Sells
5 · $14.53M
Total Shares Bought
0
Total Shares Sold
120,645
Lawrence Otto Klein's Insider Trading at Oruka Therapeutics, Inc. (ORKA)
Buys
0 · $0.00
Sells
3 · $7.08M
Total Shares Bought
0
Total Shares Sold
78,458
Related Insiders
Laura Lee Sandler
officer: Chief Operating Officer
ORKASell · Sep 1, 2026
Joana Goncalves
officer: Chief Medical Officer
ORKASell · Aug 17, 2026
Arjun Agarwal
officer: Senior Vice President, Finance
ORKASell · Aug 14, 2026
Paul T Quinlan
officer: General Counsel
ORKASell · Aug 14, 2026
Fairmount Funds Management LLC
director, 10 percent owner:
ORKASell · Jul 1, 2026
Carl Dambkowski
director
ORKASell · Jun 12, 2026
KASINGER JAMES R.
General Counsel and Secretary
CRSPSell · Feb 18, 2026
Samarth Kulkarni
Chief Executive Officer
CRSPSell · Feb 18, 2026